Q32 Bio Inc. (QTTB) corrects director grant to 10,826 stock options
Rhea-AI Filing Summary
Q32 Bio Inc. director Sven Ante Lundberg reported a grant of 10,826 stock options on June 12, 2026 at an exercise price of $12.64 per share, expiring June 11, 2036. The options vest in full upon the earlier of June 12, 2027 or the next annual stockholders’ meeting, and this Form 4/A corrects the number of options originally reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lundberg Sven Ante
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1, F2 | 10,826 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,826 shares (Direct)
Footnotes (2)
- F1. This Form 4 amendment is being filed solely to amend the Form 4 filed on June 16, 2026 to correct the number of options awarded to the Reporting Person on June 12, 2026.
- F2. The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Stock options granted: 10,826 options
Exercise price: $12.6400 per share
Expiration date: 2036-06-11
+3 more
6 metrics
Stock options granted
10,826 options
Grant to director Sven Ante Lundberg on 2026-06-12
Exercise price
$12.6400 per share
Exercise price for the granted stock options
Expiration date
2036-06-11
Expiration of the granted stock options
Underlying common shares
10,826 shares
Common stock underlying the stock option grant
Post-transaction option holdings
10,826 options
Total directly held options of this grant after the transaction
Vesting reference date
June 12, 2027
Latest date when options vest, or earlier at next annual meeting
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date
4 terms
Stock Option (Right to Buy) financial
"The security title is listed as "Stock Option (Right to Buy)" for this grant."
exercise price financial
"The options carry an exercise price of $12.6400 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares underlying this option shall vest and become exercisable in full."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"The option’s expiration date is reported as 2036-06-11."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Q32 Bio Inc. (QTTB) disclose in this Form 4/A?
Q32 Bio Inc. reported that director Sven Ante Lundberg received a grant of 10,826 stock options on June 12, 2026. These options are exercisable at $12.64 per share and represent a new derivative position reported as directly owned.
How many stock options were granted to Sven Ante Lundberg at Q32 Bio Inc. (QTTB)?
Sven Ante Lundberg was granted 10,826 stock options in Q32 Bio Inc. common stock. Following this grant, he held 10,826 of these options, all reported as directly owned in the amended Form 4 filing.
What is the exercise price and expiration date of the Q32 Bio (QTTB) options granted?
The granted options carry an exercise price of $12.64 per share and expire on June 11, 2036. These terms define the cost to acquire common shares and the final date by which the options must be exercised.
When do Sven Ante Lundberg’s Q32 Bio (QTTB) stock options vest?
The options vest and become fully exercisable upon the earlier of June 12, 2027 or Q32 Bio’s next annual stockholders’ meeting. Vesting is subject to his continued service on the vesting date, as specified in the footnotes.
Why was this Q32 Bio Inc. (QTTB) Form 4 amended?
The Form 4/A states it was filed solely to correct the number of options awarded to Sven Ante Lundberg on June 12, 2026. The amendment clarifies the accurate grant size of 10,826 options tied to Q32 Bio common stock.